Skip to main content
Have a personal or library account? Click to login
Diagnosis of Fanconi's Anemia by Diepoxybutane Analysis in Children from Serbia Cover

Diagnosis of Fanconi's Anemia by Diepoxybutane Analysis in Children from Serbia

Balkan Journal of Medical Genetics
Volume 14 (2011): Issue 2 (December 2011)
By: ,  ,  ,  ,  ,   and    
Open Access
|Dec 2011
References

References

  1. Alter BP. Inherited bone marrow failure syndromes. In: Handin RI, Stossel TP, Lux SE, Eds. Blood: Principles and Practice of Hematology. Philadelphia: JB Lippincott. 1995: 227-291.
    Search in Google Scholar
  2. Bagby GC, Lipton JM, Sloand EM, Schiffer CA. Marrow failure. Hematology Am Soc Hematol Educ Program. 2004: 318-336.
    Open DOISearch in Google Scholar
  3. Moldovan GL, D'Andrea AD. How the Fanconi anemia pathway guards the genome. Annu Rev Genet. 2009; 43: 223-249.
    Open DOISearch in Google Scholar
  4. Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet. 2007; 8(10): 735-748.
    Open DOISearch in Google Scholar
  5. Vaz F, Hanenberg H, Schuster B, Barker K, Wiek C, Erven V, Neveling K, Endt D, Kesterton I, Autore F, Fraternali F, Freund M, Hartmann L, Grimwade D, Roberts RG, Schaal H, Mohammed S, Rahman N, Schindler D, Mathew CG. Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet. 2010; 42(5): 406-409.
    Open DOISearch in Google Scholar
  6. Stoepker C, Hain K, Schuster B, Hilhorst-Hofstee Y, Rooimans MA, Steltenpool J, Oostra AB, Eirich K, Korthof ET, Nieuwint AW, Jaspers NG, Bettecken T, Joenje H, Schindler D, Rouse J, de Winter JP. SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype. Nat Genet. 2011; 43(2): 138-141.
    Open DOISearch in Google Scholar
  7. Dallapiccola B, Porfirio B, Mokini V, Alimena G, Isacchi G., Gandini E. Effect of oxidants and antioxidants on chromosomal breakage in Fanconi's anemia lymphocytes. Hum Genet. 1985; 69(1): 62-65.
    Open DOISearch in Google Scholar
  8. Joenje H, Eriksson AW, Frants RR, Arwert F, Houwen B. Erythrocyte superoxide dismutase deficiency in Fanconi's anemia. Nature. 1978; 290(8057): 142-143.
    Search in Google Scholar
  9. Schindler D, Hoehn H. Fanconi anemia mutation causes cellular susceptibility to ambient oxygen. Am J Hum Genet. 1988; 43(4): 429-435.
    Search in Google Scholar
  10. Petrovic S, Leskovac A, Kotur-Stevuljevic J, Joksic I, Guc-Scekic M, Vujic D, Joksic G. Gender-related differences in the oxidant state of cells in Fanconi anemia heterozygotes. Biol Chem. 2011; 392(7): 625-632.
    Open DOISearch in Google Scholar
  11. Auerbach AD. A test for Fanconi's anemia. Blood. 1988; 72(1): 366-367.
    Open DOISearch in Google Scholar
  12. Auerbach AD. Diagnosis of Fanconi anemia by diepoxybutane analysis. In: Dracopoli NC, Ed. Short Protocols in Human Genetics: a Compendium of Methods From Current Protocols in Human Genetics. Hoboken: J. Wiley. 2004: 31-37.
    Open DOISearch in Google Scholar
  13. Sasaki MS, Tonomura A. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross linking agents. Cancer Res. 1973; 33(8): 1829-1836.
    Search in Google Scholar
  14. Wegner R-D, Stumm M. Diagnosis of chromosomal instability syndromes. In: Wegner R-D, Ed. Diagnostic Cytogenetics. Berlin: Springer-Verlag. 1999: 251-268.
    Open DOISearch in Google Scholar
  15. An International System for Cytogenetic Nomenclature (ISCN 2009). In: Schaffer LG, Tommerup N, Eds. Basel: S. Karger, 2009.
    Search in Google Scholar
  16. Auerbach AD, Rogatko A, Schroeder-Kurth TM, International Fanconi Anemia Registry. Relation of clinical symptoms to diepoxybutane sensitivity. Blood. 1989; 73(2): 391-396.
    Open DOISearch in Google Scholar
  17. Alter BP. Fanconi's anemia and malignancies. Am J Hematol. 1996; 53(2): 99-110.
    Open DOISearch in Google Scholar
  18. Dokal I, Vulliamy T. Inherited bone marrow failure syndromes. Haematologica. 2010; 95(8): 1236-1240.
    Open DOISearch in Google Scholar
  19. Esmer C, Sanchez S, Ramos S, Molina B, Frias S, Carnavale A. DEB test for Fanconi anemia detection in patients with atypical phenotypes. Am J Med Genet. 2004; 124(1): 35-39.
    Open DOISearch in Google Scholar
  20. Liu JM, Buchwald M, Walsh CE, Young NS. Fanconi anemia and novel strategies for therapy. Blood. 1994; 12(84): 3995-4007.
    Open DOISearch in Google Scholar
  21. Najean Y, Pecking A, Le Danvic M. Androgen therapy in aplastic anemia in childhood. A prospective study of 352 cases. Scand J Haematol. 1976; 22(4): 343-356.
    Open DOISearch in Google Scholar
  22. Kook H, Cho D, Cho SH, Hong WP, Kim CJ, Park JY, Yoon WS, Ryang DW, Hwang TJ. Fanconi anemia screening by diepoxybutane and mitomycin C tests in Korean children with bone marrow failure syndromes. J Korean Med Sci. 1998; 13(6): 623-628.
    Open DOISearch in Google Scholar
  23. Cho SH, Kook H, Kim GM, Yoon WS, Cho TH, Hwang TJ. A clinical study of Fanconi's anemia. Korean J Pediatr Hematol Oncol. 1997; 4(1): 70-77.
    Search in Google Scholar
  24. Ilgin H, Akarsu AN, Bokesoy FI. Cytogenetic and phenotypic findings in Turkish patients with Fanconi anemia. Tr J Med Sci. 1999; 29(2): 151-154.
    Search in Google Scholar
  25. Soulier J, Leblanc T, Larghero J, Dastot H, Shimamura A, Guardiola P, Esperou H, Ferry C, Jubert C, Feugeas JP, Henri A, Toubert A, Socie G, Baruchel A, Sigaux F, D'Andrea AD, Gluckman E. Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway. Blood. 2005; 105(3): 1329-1336.
    Open DOISearch in Google Scholar
  26. Kwee ML, Poll EH, van de Kamp JJ, de Koning H, Eriksson AW, Joenje H. Unusual response to bifunctional alkylating agents in a case of Fanconi anaemia. Hum Genet. 1983; 64(4): 384-387.
    Open DOISearch in Google Scholar
  27. Lo Ten Foe JR, Kwee ML, Rooimans MA, Oostra AB, Veerman AJ, van Weel M, Pauli RM, Shahidi NT, Dokal I, Roberts I, Altay C, Gluckman E, Gibson RA, Mathew CG, Arwert F, Joenje H. Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet. 1997; 5(3): 137-148.
    Open DOISearch in Google Scholar
  28. Gross M, Hanenberg H, Lobitz S, Friedl R, Herterich S, Dietrich R, Gruhn B, Schindler D, Hoehn H. Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction. Cytogenet Genome Res. 2002; 98(2-3): 126-135.
    Open DOISearch in Google Scholar
  29. Youssoufian H. Natural gene therapy and the Darwinian legacy. Nat Genet. 1996; 13(3): 255-256.
    Open DOISearch in Google Scholar
  30. Castella M, Pujol R, Callén E, Ramírez MJ, Casado JA, Talavera M, Ferro T, Muñoz A, Sevilla J, Madero L, Cela E, Beléndez C, de Heredia CD, Olivé T, de Toledo JS, Badell I, Estella J, Dasí Á, Rodríguez-Villa A, Gómez P, Tapia M, Molinés A, Figuera Á, Bueren JA, Surrallés J. Chromosome fragility in patients with Fanconi anaemia: diagnostic implications and clinical impact. J Med Genet. 2011; 48(4): 242-250.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10034-011-0048-6 | Journal eISSN: 2199-5761 (formerly 1311-0160) | Journal ISSN: 1311-0160
Journal RSS Feed
Language: English
Page range: 65 - 70
Published on: Dec 8, 2011
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Keywords:
Chromosome fragility,
Diepoxybutane (DEB),
Fanconi's anemia (FA)
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2011 S Cirkovic, M Guc-Scekic, D Vujic, N Ilic, D Micic, D Skoric, A Jovanovic, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons License.

Volume 14 (2011): Issue 2 (December 2011)
Previous article
Next article